| Literature DB >> 26551668 |
Shazia S Mahamdallie1, Sandra Hanks1, Kristen L Karlin2,3, Anna Zachariou1, Elizabeth R Perdeaux1, Elise Ruark1, Chad A Shaw3, Alexander Renwick3, Emma Ramsay1, Shawn Yost1, Anna Elliott1, Jillian Birch4, Michael Capra5, Juliet Gray6, Juliet Hale7, Judith Kingston8, Gill Levitt8, Thomas McLean9, Eamonn Sheridan10, Anthony Renwick1, Sheila Seal1, Charles Stiller11, Neil Sebire12, Thomas F Westbrook2,3, Nazneen Rahman1,13.
Abstract
Wilms tumor is the most common childhood renal cancer. To identify mutations that predispose to Wilms tumor, we are conducting exome sequencing studies. Here we describe 11 different inactivating mutations in the REST gene (encoding RE1-silencing transcription factor) in four familial Wilms tumor pedigrees and nine non-familial cases. Notably, no similar mutations were identified in the ICR1000 control series (13/558 versus 0/993; P < 0.0001) or in the ExAC series (13/558 versus 0/61,312; P < 0.0001). We identified a second mutational event in two tumors, suggesting that REST may act as a tumor-suppressor gene in Wilms tumor pathogenesis. REST is a zinc-finger transcription factor that functions in cellular differentiation and embryonic development. Notably, ten of 11 mutations clustered within the portion of REST encoding the DNA-binding domain, and functional analyses showed that these mutations compromise REST transcriptional repression. These data establish REST as a Wilms tumor predisposition gene accounting for ∼2% of Wilms tumor.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26551668 DOI: 10.1038/ng.3440
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330